 |
|
Influence of Thyroid-stimulating Hormone Suppression Therapy on Bone Mineral Density in Patients with Differentiated Thyroid Cancer: A Meta-analysis
Byung-Ho Yoon, Youjin Lee, Hyun Jin Oh, Sung Han Kim, Young-Kyun Lee
J Bone Metab. 2019;26(1):51-60. Published online 2019 Feb 28 DOI: https://doi.org/10.11005/jbm.2019.26.1.51
|
|
Citations to this article as recorded by
 Association between serum TSH concentration and bone mineral density: an umbrella review
Martyna Dziedzic, Michał Bonczar, Patryk Ostrowski, Bartłomiej Stachera, Dawid Plutecki, Monika Buziak-Bereza, Alicja Hubalewska-Dydejczyk, Jerzy Walocha, Mateusz Koziej
Hormones.2024;[Epub] CrossRef How does Hashimoto’s thyroiditis affect bone metabolism?
Jialu Wu, Hui Huang, Xijie Yu
Reviews in Endocrine and Metabolic Disorders.2023; 24(2): 191. CrossRef Levothyroxine suppressive therapy in differentiated thyroid cancer treatment
Jan Drugda, Jan Čáp, Mikuláš Kosák, Filip Gabalec
Vnitřní lékařství.2023; 69(2): 128. CrossRef Evaluation and Management of Bone Health in Patients with Thyroid Diseases: A Position Statement of the Korean Thyroid Association
A Ram Hong, Ho-Cheol Kang
Endocrinology and Metabolism.2023; 38(2): 175. CrossRef Factors related to bone mineral density in female patients receiving TSH-suppressive doses of levothyroxine for thyroid cancer
Araya Boonyaleepan, Tarit Taerakul
The ASEAN Journal of Radiology.2023; 24(2): 98. CrossRef Risk factors for thyroid hormone replacement therapy after hemithyroidectomy and development of a predictive nomogram
Zhen Cao, Rui Liu, Mengwei Wu, Xiequn Xu, Ziwen Liu
Endocrine.2022; 76(1): 85. CrossRef Bone‐density testing interval and transition to osteoporosis in differentiated thyroid carcinoma patients on TSH suppression therapy
Hyunju Park, Jun Park, Heejin Yoo, Seonwoo Kim, Jang Hyun Koh, Jae Hwan Jee, Yong‐Ki Min, Jae Hoon Chung, Tae Hyuk Kim, Mira Kang, Sun Wook Kim
Clinical Endocrinology.2022; 97(1): 130. CrossRef Effects and Mechanisms of Rhus chinensis Mill. Fruits on Suppressing RANKL-Induced Osteoclastogenesis by Network Pharmacology and Validation in RAW264.7 Cells
Yue Zheng, Lei Zhao, Junjie Yi, Shengbao Cai
Nutrients.2022; 14(5): 1020. CrossRef Evaluation and Management of Bone Health in Patients with Thyroid Diseases: a Position Statement from the Korean Thyroid Association
A Ram Hong, Hwa Young Ahn, Bu Kyung Kim, Seong Hee Ahn, So Young Park, Min-Hee Kim, Jeongmin Lee, Sun Wook Cho, Ho-Cheol Kang
International Journal of Thyroidology.2022; 15(1): 1. CrossRef Effects of TSH suppressive therapy on bone mineral density (BMD) and bone turnover markers (BTMs) in patients with differentiated thyroid cancer in Northeast China: a prospective controlled cohort study
Shiwei Wang, Yu Wang, Li Zhu, Liang He, Mutian Lv, Hao Zhang, Haoyu Wang, Fan Zhang, Yaxin Lai, Yushu Li, Zhongyan Shan, Weiping Teng
Endocrine.2022; 79(1): 113. CrossRef Application and prospect of trabecular bone score in differentiated thyroid cancer patients receiving thyrotropin suppression therapy
Bingyu Ran, Feng Wei, Jian Gong, Hao Xu
Frontiers in Endocrinology.2022;[Epub] CrossRef The risk between thyrotropin suppression and bone mineral density in differentiated thyroid cancer
Yang Zou, Bin Li, Xiaodong Wang, Jingxin Mao, Yanyan Zhang
Medicine.2022; 101(48): e31991. CrossRef Skeletal health in patients with differentiated thyroid carcinoma
M. Cellini, M. Rotondi, M. L. Tanda, E. Piantanida, L. Chiovato, P. Beck-Peccoz, Andrea Lania, G. Mazziotti
Journal of Endocrinological Investigation.2021; 44(3): 431. CrossRef Trabecular bone score in women with differentiated thyroid cancer on long-term TSH-suppressive therapy
B. É. C. A. Sousa, B. C. Silva, T. de Oliveira Guidotti, M. C. Pires, M. M. S. Soares, A. M. Kakehasi
Journal of Endocrinological Investigation.2021; 44(10): 2295. CrossRef Effects of thyroid-stimulating hormone suppression after thyroidectomy for thyroid cancer on bone mineral density in postmenopausal women: a systematic review and meta-analysis
Donghee Kwak, Jane Ha, Yousun Won, Yeongkeun Kwon, Sungsoo Park
BMJ Open.2021; 11(5): e043007. CrossRef Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis
Eu Jeong Ku, Won Sang Yoo, Eun Kyung Lee, Hwa Young Ahn, Seung Hoon Woo, Jun Hwa Hong, Hyun Kyung Chung, Jin-Woo Park
The Journal of Clinical Endocrinology & Metabolism.2021;[Epub] CrossRef Thyrotropin, Hyperthyroidism, and Bone Mass
Se-Min Kim, Vitaly Ryu, Sari Miyashita, Funda Korkmaz, Daria Lizneva, Sakshi Gera, Rauf Latif, Terry F Davies, Jameel Iqbal, Tony Yuen, Mone Zaidi
The Journal of Clinical Endocrinology & Metabolism.2021;[Epub] CrossRef TSH Suppression Therapy for Differentiated Thyroid Cancer May Be Associated with Lower Bone Density in Postmenopausal Women
Sun Y. Lee
Clinical Thyroidology.2021; 33(9): 406. CrossRef Thyroid Hormone Diseases and Osteoporosis
Alessandro P. Delitala, Angelo Scuteri, Carlo Doria
Journal of Clinical Medicine.2020; 9(4): 1034. CrossRef The Molecular Function and Clinical Role of Thyroid Stimulating Hormone Receptor in Cancer Cells
Yu-De Chu, Chau-Ting Yeh
Cells.2020; 9(7): 1730. CrossRef Bone mineral density and its correlation with serum 25-hydroxyvitamin D levels in patients with hyperthyroidism
Haixia Liu, Qihang Ma, Xinli Han, Wenwen Huang
Journal of International Medical Research.2020; 48(2): 030006052090366. CrossRef Integrated pathological cell fishing and network pharmacology approach to investigate main active components of Er-Xian decotion for treating osteoporosis
Nani Wang, Pingcui Xu, Xuping Wang, Weixuan Yao, Zhongming Yu, Renjie Wu, Xiaowen Huang, Yuyang Si, Dan Shou
Journal of Ethnopharmacology.2019; 241: 111977. CrossRef Thyroid hormone therapy in differentiated thyroid cancer
Giorgio Grani, Valeria Ramundo, Antonella Verrienti, Marialuisa Sponziello, Cosimo Durante
Endocrine.2019; 66(1): 43. CrossRef
|